Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study

This study evaluated health outcomes among people who inject drugs who are infected with hepatitis C virus using an artificial intelligence platform. Mean (SD) cumulative adherence (visual confirmation of administration) was 91.3% (10.5%). Most subjects (88.2%) achieved ≥80% adherence to treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Litwin, Alain H, Shafner, Laura, Norton, Brianna, Akiyama, Matthew J, Agyemang, Linda, Guzman, Mercedes, Vera, Tatiana, Heo, Moonseong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423287/
https://www.ncbi.nlm.nih.gov/pubmed/32818140
http://dx.doi.org/10.1093/ofid/ofaa290
Descripción
Sumario:This study evaluated health outcomes among people who inject drugs who are infected with hepatitis C virus using an artificial intelligence platform. Mean (SD) cumulative adherence (visual confirmation of administration) was 91.3% (10.5%). Most subjects (88.2%) achieved ≥80% adherence to treatment, and 88.2% (15 of 17) achieved a sustained virologic response.

Ejemplares similares